For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Covid-19 update: 2640 new cases, 30 further deaths
Covid-19 update: 2640 new cases, 30 further deaths

There have been 2640 new cases of Covid-19 reported in New Zealand over the week to Sunday, and 30 further deaths attributed to the virus.
Of the new cases, 1617 were reinfections.
There were 169 cases in hospital and none in ICU.
The greatest number of new cases reported over the past week were in Canterbury (320), followed by Waitematā (264), and Counties Manukau (252).
Last week, Te Whatu Ora reported 2772 new cases of Covid-19 over the week, and 31 further deaths attributed to the virus.
Te Whatu Ora also noted last week it had updated the 24 June figures, correcting an issue with reported cases and related hospital admissions which had led to an undercount being published.
For more news from around New Zealand, go to RNZ.